NON-INFERIORITY STUDY OF A METRONIDAZOLE 0.75% CREAM VERSUS REFERENCE THERAPY IN THE LOCAL TREATMENT OF PAPULOPUSTULAR ROSACEA.

Registry ID

EUCTR2006-007029-29

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre

Start date

2007-11-16

Completion date

2008-05-13

Last update

2026-08-16

Conditions

• Papulopustular Rosacea

Summary

To assess the non-inferiority of a metronidazole 0.75% cream (Rosiced) in comparison to reference therapy (Rozex) in the local treatment of papulopustular rosacea

Locations

• , , Germany
• , , France
• , , Austria
• , , Estonia
• , , Latvia
• , , Sweden

Related clinical trials

• A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
• Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

View on source registry